108 related articles for article (PubMed ID: 27094149)
1. Screening and target identification of bioactive compounds that modulate cell migration and autophagy.
Tashiro E; Imoto M
Bioorg Med Chem; 2016 Aug; 24(15):3283-90. PubMed ID: 27094149
[TBL] [Abstract][Full Text] [Related]
2. Chemistry and biology of the compounds that modulate cell migration.
Tashiro E; Imoto M
J Ind Microbiol Biotechnol; 2016 Mar; 43(2-3):213-9. PubMed ID: 26173498
[TBL] [Abstract][Full Text] [Related]
3. Actin Filament Structures in Migrating Cells.
Lehtimäki J; Hakala M; Lappalainen P
Handb Exp Pharmacol; 2017; 235():123-152. PubMed ID: 27469496
[TBL] [Abstract][Full Text] [Related]
4. Phenotype-driven chemical screening in zebrafish for compounds that inhibit collective cell migration identifies multiple pathways potentially involved in metastatic invasion.
Gallardo VE; Varshney GK; Lee M; Bupp S; Xu L; Shinn P; Crawford NP; Inglese J; Burgess SM
Dis Model Mech; 2015 Jun; 8(6):565-76. PubMed ID: 25810455
[TBL] [Abstract][Full Text] [Related]
5. Proteomic profiling of human cancer pseudopodia for the identification of anti-metastatic drug candidates.
Choi S; Bhagwat AM; Al Mismar R; Goswami N; Ben Hamidane H; Sun L; Graumann J
Sci Rep; 2018 Apr; 8(1):5858. PubMed ID: 29643415
[TBL] [Abstract][Full Text] [Related]
6. ING5 suppresses proliferation, apoptosis, migration and invasion, and induces autophagy and differentiation of gastric cancer cells: a good marker for carcinogenesis and subsequent progression.
Gou WF; Shen DF; Yang XF; Zhao S; Liu YP; Sun HZ; Su RJ; Luo JS; Zheng HC
Oncotarget; 2015 Aug; 6(23):19552-79. PubMed ID: 25980581
[TBL] [Abstract][Full Text] [Related]
7. Bioactive Compounds from
Leri M; Ramazzotti M; Vasarri M; Peri S; Barletta E; Pretti C; Degl'Innocenti D
Mar Drugs; 2018 Apr; 16(4):. PubMed ID: 29690502
[No Abstract] [Full Text] [Related]
8. Overexpression of HER2 signaling to WAVE2-Arp2/3 complex activates MMP-independent migration in breast cancer.
Yokotsuka M; Iwaya K; Saito T; Pandiella A; Tsuboi R; Kohno N; Matsubara O; Mukai K
Breast Cancer Res Treat; 2011 Apr; 126(2):311-8. PubMed ID: 20419393
[TBL] [Abstract][Full Text] [Related]
9. Deguelin inhibits the migration and invasion of lung cancer A549 and H460 cells via regulating actin cytoskeleton rearrangement.
Zhao H; Jiao Y; Zhang Z
Int J Clin Exp Pathol; 2015; 8(12):15582-90. PubMed ID: 26884827
[TBL] [Abstract][Full Text] [Related]
10. Seeking new anti-cancer agents from autophagy-regulating natural products.
Hua F; Shang S; Hu ZW
J Asian Nat Prod Res; 2017 Apr; 19(4):305-313. PubMed ID: 28347180
[TBL] [Abstract][Full Text] [Related]
11. TNFalpha induces sequential activation of Cdc42- and p38/p53-dependent pathways that antagonistically regulate filopodia formation.
Gadea G; Roger L; Anguille C; de Toledo M; Gire V; Roux P
J Cell Sci; 2004 Dec; 117(Pt 26):6355-64. PubMed ID: 15561766
[TBL] [Abstract][Full Text] [Related]
12. Metabolomic identification of the target of the filopodia protrusion inhibitor glucopiericidin A.
Kitagawa M; Ikeda S; Tashiro E; Soga T; Imoto M
Chem Biol; 2010 Sep; 17(9):989-98. PubMed ID: 20851348
[TBL] [Abstract][Full Text] [Related]
13. Chemical biology of compounds obtained from screening using disease models.
Tashiro E; Imoto M
Arch Pharm Res; 2015 Sep; 38(9):1651-60. PubMed ID: 26177809
[TBL] [Abstract][Full Text] [Related]
14. Autophagy inhibition suppresses pulmonary metastasis of HCC in mice via impairing anoikis resistance and colonization of HCC cells.
Peng YF; Shi YH; Ding ZB; Ke AW; Gu CY; Hui B; Zhou J; Qiu SJ; Dai Z; Fan J
Autophagy; 2013 Dec; 9(12):2056-68. PubMed ID: 24157892
[TBL] [Abstract][Full Text] [Related]
15. Autophagy induction by silibinin positively contributes to its anti-metastatic capacity via AMPK/mTOR pathway in renal cell carcinoma.
Li F; Ma Z; Guan Z; Chen Y; Wu K; Guo P; Wang X; He D; Zeng J
Int J Mol Sci; 2015 Apr; 16(4):8415-29. PubMed ID: 25884331
[TBL] [Abstract][Full Text] [Related]
16. Ginsenoside 20(S)-Rg3 induced autophagy to inhibit migration and invasion of ovarian cancer.
Zheng X; Chen W; Hou H; Li J; Li H; Sun X; Zhao L; Li X
Biomed Pharmacother; 2017 Jan; 85():620-626. PubMed ID: 27899249
[TBL] [Abstract][Full Text] [Related]
17. Filopodia formation mediated by receptor tyrosine kinase Ror2 is required for Wnt5a-induced cell migration.
Nishita M; Yoo SK; Nomachi A; Kani S; Sougawa N; Ohta Y; Takada S; Kikuchi A; Minami Y
J Cell Biol; 2006 Nov; 175(4):555-62. PubMed ID: 17101698
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of tumor cell growth, proliferation and migration by X-387, a novel active-site inhibitor of mTOR.
Chen SM; Liu JL; Wang X; Liang C; Ding J; Meng LH
Biochem Pharmacol; 2012 May; 83(9):1183-94. PubMed ID: 22305748
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel small compounds that restore E-cadherin expression and inhibit tumor cell motility and invasiveness.
Hirano T; Satow R; Kato A; Tamura M; Murayama Y; Saya H; Kojima H; Nagano T; Okabe T; Fukami K
Biochem Pharmacol; 2013 Nov; 86(10):1419-29. PubMed ID: 24035834
[TBL] [Abstract][Full Text] [Related]
20. [Metabolomics and molecular targeted therapy of cancer].
Tashiro E; Imoto M
Nihon Rinsho; 2015 Aug; 73(8):1268-72. PubMed ID: 26281677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
